المؤلفون: Nishiyama M; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Takeda S; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Watanabe Y; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Iida M; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Yamamoto T; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Nakashima C; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Matsui H; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Shindo Y; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Tokumitsu Y; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Tomochika S; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan., Ioka T; Oncology Center, Yamaguchi University Hospital, Ube, Japan., Nagano H; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan; hnagano@yamaguchi-u.ac.jp.

المصدر: In vivo (Athens, Greece) [In Vivo] 2024 Jul-Aug; Vol. 38 (4), pp. 1790-1798.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8806809 Publication Model: Print Cited Medium: Internet ISSN: 1791-7549 (Electronic) Linking ISSN: 0258851X NLM ISO Abbreviation: In Vivo Subsets: MEDLINE

مواضيع طبية MeSH: Esophagectomy*/adverse effects , Esophagectomy*/methods , Esophageal Neoplasms*/surgery , Pneumonia*/prevention & control , Pneumonia*/etiology , Pneumonia*/epidemiology , Piperacillin, Tazobactam Drug Combination*/therapeutic use , Piperacillin, Tazobactam Drug Combination*/administration & dosage , Postoperative Complications*/prevention & control , Postoperative Complications*/etiology, Humans ; Male ; Female ; Aged ; Middle Aged ; Anti-Bacterial Agents/therapeutic use ; Anti-Bacterial Agents/administration & dosage ; Retrospective Studies ; Risk Factors

المؤلفون: Pipkin T; Department of Pharmacy, Emory University Hospital, Atlanta, GA, USA., Pope S; Department of Pharmacy, Emory University Hospital Midtown, Atlanta, GA, USA., Killian A; Department of Pharmacy, Emory University Hospital, Atlanta, GA, USA., Green S; Department of Pharmacy, Emory University Hospital, Atlanta, GA, USA., Albrecht B; Department of Pharmacy, Emory University Hospital, Atlanta, GA, USA., Nugent K; Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.; Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA, USA.; Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA, USA.; Division of Critical Care Medicine, Emory University School of Medicine, Atlanta, GA, USA.

المصدر: Journal of intensive care medicine [J Intensive Care Med] 2024 Sep; Vol. 39 (9), pp. 860-865. Date of Electronic Publication: 2024 Feb 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 8610344 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1489 (Electronic) Linking ISSN: 08850666 NLM ISO Abbreviation: J Intensive Care Med Subsets: MEDLINE

مواضيع طبية MeSH: Vancomycin*/adverse effects , Vancomycin*/administration & dosage , Acute Kidney Injury*/chemically induced , Piperacillin, Tazobactam Drug Combination*/adverse effects , Piperacillin, Tazobactam Drug Combination*/administration & dosage , Critical Illness*/therapy , Anti-Bacterial Agents*/adverse effects , Anti-Bacterial Agents*/administration & dosage , Renal Insufficiency, Chronic*/complications , Drug Therapy, Combination*/adverse effects, Humans ; Male ; Female ; Retrospective Studies ; Middle Aged ; Aged ; Hospital Mortality ; Intensive Care Units ; Length of Stay/statistics & numerical data ; Risk Factors ; Incidence

المؤلفون: Woldesenbet D; Department of Medical Laboratory Science, College of Medicine and Health Sciences, Wachemo University, Hossana, Ethiopia. dagmawi2929@gmail.com., Birhanie M; Department of Medical Parasitology, School of Biomedical and Laboratory Science, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia., Abere A; Department of Medical Parasitology, School of Biomedical and Laboratory Science, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia., Zeleke AJ; Department of Medical Parasitology, School of Biomedical and Laboratory Science, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia., Bezabih MK; Malaria and Neglected Tropical Diseases Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Semaw M; Medical Laboratory Unit, Sanja General Hospital, Amhara National Regional State Health Bureau, Sanja, Ethiopia., Wubetie M; Department of Medical Laboratory Science, College of Medicine and Health Sciences, Dire Dawa University, Dire Dawa, Ethiopia., Abebe W; Department of Medical Laboratory Science, College of Medicine and Health Sciences, Woldia University, Woldia, Ethiopia., Tamene E; Department of Medical Laboratory Science, College of Medicine and Health Sciences, Wachemo University, Hossana, Ethiopia., Tegegne Y; Department of Medical Parasitology, School of Biomedical and Laboratory Science, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.

المصدر: Malaria journal [Malar J] 2024 Aug 30; Vol. 23 (1), pp. 266. Date of Electronic Publication: 2024 Aug 30.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875 (Electronic) Linking ISSN: 14752875 NLM ISO Abbreviation: Malar J Subsets: MEDLINE

مواضيع طبية MeSH: Malaria, Falciparum*/drug therapy , Artemether, Lumefantrine Drug Combination*/therapeutic use , Artemether, Lumefantrine Drug Combination*/adverse effects , Antimalarials*/therapeutic use , Antimalarials*/adverse effects , Antimalarials*/administration & dosage, Ethiopia ; Humans ; Male ; Female ; Adult ; Prospective Studies ; Adolescent ; Young Adult ; Middle Aged ; Child ; Child, Preschool ; Plasmodium falciparum/drug effects ; Drug Combinations

المؤلفون: Rangatchew F; Department of Plastic Surgery and Burn Treatment, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark. Electronic address: filip.rangatchew@hotmail.com., Schoelzer L; Faculty of Health and Medical Sciences Panum, University of Copenhagen, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark., Drzewiecki KT; Department of Plastic Surgery and Burn Treatment, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark., Holmgaard R; Department of Plastic Surgery and Burn Treatment, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.

المصدر: Journal of plastic, reconstructive & aesthetic surgery : JPRAS [J Plast Reconstr Aesthet Surg] 2024 Aug; Vol. 95, pp. 386-401. Date of Electronic Publication: 2024 Apr 10.

نوع المنشور: Systematic Review; Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101264239 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0539 (Electronic) Linking ISSN: 17486815 NLM ISO Abbreviation: J Plast Reconstr Aesthet Surg Subsets: MEDLINE

مواضيع طبية MeSH: Burns*/complications , Burns*/therapy , Lidocaine, Prilocaine Drug Combination*/pharmacokinetics , Lidocaine, Prilocaine Drug Combination*/administration & dosage , Anesthetics, Local*/pharmacokinetics , Anesthetics, Local*/administration & dosage , Anesthetics, Local*/adverse effects, Humans ; Animals ; Pain, Procedural/etiology ; Prilocaine/pharmacokinetics ; Prilocaine/administration & dosage ; Lidocaine/pharmacokinetics ; Lidocaine/administration & dosage

المؤلفون: Wang M; Shandong Provincial Clinical Research Centre for Children's Health and Disease, Jinan, China; Department of Microbiology Laboratory, Children's Hospital Affiliated to Shandong University, Jinan, China., Hao M; Clinical Laboratory, Shandong Provincial Qianfoshan Hospital, Jinan, China., Cui X; Clinical Laboratory, Shandong Provincial Qianfoshan Hospital, Jinan, China., Liu M; Clinical Laboratory, Jinan Dermatosis Prevention and Control Hospital, Jinan, China., Zhang C; Shandong Provincial Clinical Research Centre for Children's Health and Disease, Jinan, China; Department of Microbiology Laboratory, Children's Hospital Affiliated to Shandong University, Jinan, China., Wang S; Shandong Provincial Clinical Research Centre for Children's Health and Disease, Jinan, China; Department of Microbiology Laboratory, Children's Hospital Affiliated to Shandong University, Jinan, China. Electronic address: wshfu709@163.com.

المصدر: International journal of antimicrobial agents [Int J Antimicrob Agents] 2024 Aug; Vol. 64 (2), pp. 107237. Date of Electronic Publication: 2024 Jun 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7913 (Electronic) Linking ISSN: 09248579 NLM ISO Abbreviation: Int J Antimicrob Agents Subsets: MEDLINE

مواضيع طبية MeSH: beta-Lactamases*/genetics , Klebsiella pneumoniae*/genetics , Klebsiella pneumoniae*/drug effects , Klebsiella Infections*/drug therapy , Klebsiella Infections*/microbiology , Klebsiella Infections*/epidemiology , Microbial Sensitivity Tests* , Anti-Bacterial Agents*/pharmacology , Anti-Bacterial Agents*/therapeutic use , Trimethoprim, Sulfamethoxazole Drug Combination*/pharmacology , Trimethoprim, Sulfamethoxazole Drug Combination*/therapeutic use , Plasmids*/genetics , Disease Outbreaks*, Humans ; China/epidemiology ; Drug Resistance, Multiple, Bacterial/genetics ; Whole Genome Sequencing ; Drug Combinations ; Ceftazidime/pharmacology ; Ceftazidime/therapeutic use ; Azabicyclo Compounds/pharmacology ; Azabicyclo Compounds/therapeutic use ; Bacterial Proteins/genetics ; Tertiary Care Centers

المؤلفون: Zhang B; Department of Urinary Surgery, Institute of Urology, Peking University First Hospital, Peking University, Beijing, China., Wang Y; Department of Gastrointestinal Surgery, Peking University First Hospital, No.8 Xishku Street, Xicheng District, Beijing, China. pkudocyoung@outlook.com.

المصدر: World journal of urology [World J Urol] 2024 Jul 10; Vol. 42 (1), pp. 403. Date of Electronic Publication: 2024 Jul 10.

نوع المنشور: Letter; Comparative Study; Comment

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 8307716 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-8726 (Electronic) Linking ISSN: 07244983 NLM ISO Abbreviation: World J Urol Subsets: MEDLINE

مواضيع طبية MeSH: Ciprofloxacin*/therapeutic use , Ciprofloxacin*/administration & dosage , Fosfomycin*/therapeutic use , Fosfomycin*/administration & dosage , Prostate*/pathology , Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/administration & dosage , Trimethoprim, Sulfamethoxazole Drug Combination*/therapeutic use , Trimethoprim, Sulfamethoxazole Drug Combination*/administration & dosage, Humans ; Male ; Antibiotic Prophylaxis/methods ; Drug Therapy, Combination ; Biopsy/methods ; Biopsy/adverse effects

المؤلفون: Exarchos KP; Respiratory Medicine Department, University of Ioannina School of Medicine, Ioannina, Greece., Hillas G; 5th Pulmonary Department, 'Sotiria' Chest Diseases Hospital, Athens, Greece., Steiropoulos P; Department of Respiratory Medicine, Medical School, Democritus University of Thrace, Alexandroupolis, Greece., Papanastasiou P; Medical Department, ELPEN Pharmaceutical Co. Inc., Athens, Greece., Gogali A; Respiratory Medicine Department, University of Ioannina School of Medicine, Ioannina, Greece., Kostikas K; Respiratory Medicine Department, University of Ioannina School of Medicine, Ioannina, Greece.

المصدر: The clinical respiratory journal [Clin Respir J] 2024 Jul; Vol. 18 (7), pp. e13803.

نوع المنشور: Journal Article; Observational Study; Multicenter Study

بيانات الدورية: Publisher: Blackwell Publishing Country of Publication: England NLM ID: 101315570 Publication Model: Print Cited Medium: Internet ISSN: 1752-699X (Electronic) Linking ISSN: 17526981 NLM ISO Abbreviation: Clin Respir J Subsets: MEDLINE

مواضيع طبية MeSH: Bronchodilator Agents*/administration & dosage , Bronchodilator Agents*/therapeutic use , Fluticasone-Salmeterol Drug Combination*/administration & dosage , Fluticasone-Salmeterol Drug Combination*/therapeutic use , Health Status* , Medication Adherence*/statistics & numerical data , Pulmonary Disease, Chronic Obstructive*/drug therapy , Pulmonary Disease, Chronic Obstructive*/physiopathology, Aged ; Female ; Humans ; Male ; Middle Aged ; Administration, Inhalation ; Albuterol/analogs & derivatives ; Albuterol/administration & dosage ; Albuterol/therapeutic use ; Drug Combinations ; Surveys and Questionnaires ; Treatment Outcome

المؤلفون: Muanda FT; ICES Western, London, Ontario, Canada.; Department of Physiology and Pharmacology, Western University, London, Ontario, Canada.; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada., Weir MA; ICES Western, London, Ontario, Canada.; Department of Physiology and Pharmacology, Western University, London, Ontario, Canada.; Division of Nephrology, Department of Medicine, Western University, London, Ontario, Canada., Ahmadi F; ICES Western, London, Ontario, Canada.; Department of Physiology and Pharmacology, Western University, London, Ontario, Canada., McArthur E; ICES Western, London, Ontario, Canada.; Lawson Health Research Institute, London Health Sciences Centre, London, Ontario, Canada., Sontrop JM; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada., Abdullah SS; ICES Western, London, Ontario, Canada.; Lawson Health Research Institute, London Health Sciences Centre, London, Ontario, Canada., Urquhart BL; Department of Physiology and Pharmacology, Western University, London, Ontario, Canada., Sadeghi H; Department of Biology, Western University, London, Ontario, Canada., Kim RB; Division of Clinical Pharmacology, Department of Medicine, Western University, London, Ontario, Canada., Garg AX; ICES Western, London, Ontario, Canada.; Department of Physiology and Pharmacology, Western University, London, Ontario, Canada.; Division of Nephrology, Department of Medicine, Western University, London, Ontario, Canada.

المصدر: Pharmacotherapy [Pharmacotherapy] 2024 Jul; Vol. 44 (7), pp. 558-569. Date of Electronic Publication: 2024 Jun 24.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8111305 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1875-9114 (Electronic) Linking ISSN: 02770008 NLM ISO Abbreviation: Pharmacotherapy Subsets: MEDLINE

مواضيع طبية MeSH: Digoxin*/adverse effects , Digoxin*/administration & dosage , Amoxicillin*/adverse effects , Amoxicillin*/administration & dosage , Trimethoprim, Sulfamethoxazole Drug Combination*/adverse effects , Trimethoprim, Sulfamethoxazole Drug Combination*/administration & dosage , Anti-Bacterial Agents*/adverse effects , Anti-Bacterial Agents*/administration & dosage, Humans ; Aged ; Female ; Male ; Aged, 80 and over ; Retrospective Studies ; Cohort Studies ; Drug Interactions ; Ontario/epidemiology ; Cardiotonic Agents/adverse effects ; Cardiotonic Agents/therapeutic use ; Cardiotonic Agents/administration & dosage

المؤلفون: Bastien G; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada., Abboud A; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada., McAnulty C; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada., Elkrief L; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada., Ledjiar O; Unité de recherche clinique appliquée, Centre hospitalier universitaire Ste-Justine, Montréal, Québec, Canada., Socias ME; British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.; Department of Medicine, Faculty of Medicine, University of British Columbia, University of British Columbia, Vancouver, British Columbia, Canada., Le Foll B; Translational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.; Department of Pharmacology and Toxicology, Faculty of Medicine, Medical Sciences Building, University of Toronto, Toronto, Ontario, Canada.; Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada., Bahji A; Department of Medicine and Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Brissette S; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Department of Family and Emergency Medicine, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada., Marsan S; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Department of Family and Emergency Medicine, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada., Jutras-Aswad D; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.

المصدر: Journal of dual diagnosis [J Dual Diagn] 2024 Jul-Sep; Vol. 20 (3), pp. 189-200. Date of Electronic Publication: 2024 Apr 05.

نوع المنشور: Journal Article; Pragmatic Clinical Trial; Randomized Controlled Trial; Multicenter Study

بيانات الدورية: Publisher: Haworth Medical Press Country of Publication: United States NLM ID: 101197457 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1550-4271 (Electronic) Linking ISSN: 15504271 NLM ISO Abbreviation: J Dual Diagn Subsets: MEDLINE

مواضيع طبية MeSH: Opioid-Related Disorders*/complications , Opioid-Related Disorders*/drug therapy , Depression*/drug therapy , Depression*/complications , Methadone*/therapeutic use , Opiate Substitution Treatment* , Buprenorphine, Naloxone Drug Combination*/therapeutic use , Severity of Illness Index*, Humans ; Male ; Female ; Adult ; Middle Aged ; Treatment Outcome ; Narcotic Antagonists/therapeutic use ; Narcotic Antagonists/administration & dosage ; Analgesics, Opioid/therapeutic use ; Analgesics, Opioid/administration & dosage

المؤلفون: Bergstrom M; HIV Services, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK., Rahim A; HIV Services, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK., Akodu J; HIV Services, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.; Pharmacy Services, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK., Marshall G; HIV Services, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.; Pharmacy Services, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK., Harrison C; Medicine and Urgent Care, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK., Penrose L; HIV Services, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK., Lipman MC; HIV Services, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.; UCL Respiratory, Division of Medicine, University College London, London, UK.; Respiratory Medicine, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK., Miller RF; HIV Services, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.; Centre for Clinical Research in Infection and Sexual Health, Institute for Global Health, University College London, London, UK.

المصدر: International journal of STD & AIDS [Int J STD AIDS] 2024 Jul; Vol. 35 (8), pp. 644-647. Date of Electronic Publication: 2024 Apr 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sage Country of Publication: England NLM ID: 9007917 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1758-1052 (Electronic) Linking ISSN: 09564624 NLM ISO Abbreviation: Int J STD AIDS Subsets: MEDLINE

مواضيع طبية MeSH: Pentamidine*/administration & dosage , Pentamidine*/therapeutic use , Pneumonia, Pneumocystis*/prevention & control , HIV Infections*/drug therapy , Trimethoprim, Sulfamethoxazole Drug Combination*/administration & dosage , Trimethoprim, Sulfamethoxazole Drug Combination*/therapeutic use , Nebulizers and Vaporizers* , AIDS-Related Opportunistic Infections*/prevention & control, Humans ; Male ; Adult ; Female ; Middle Aged ; London ; Pneumocystis carinii ; Administration, Inhalation ; Antifungal Agents/administration & dosage ; Antifungal Agents/therapeutic use